These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2944022

  • 1. Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid.
    Moroni F, Lombardi G, Robitaille Y, Etienne P.
    Neurobiol Aging; 1986; 7(4):249-53. PubMed ID: 2944022
    [Abstract] [Full Text] [Related]

  • 2. Brain quinolinic acid in Alzheimer's dementia.
    Sofic E, Halket J, Przyborowska A, Riederer P, Beckmann H, Sandler M, Jellinger K.
    Eur Arch Psychiatry Neurol Sci; 1989; 239(3):177-9. PubMed ID: 2532134
    [Abstract] [Full Text] [Related]

  • 3. Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat.
    el-Defrawy SR, Coloma F, Jhamandas K, Boegman RJ, Beninger RJ, Wirsching BA.
    Neurobiol Aging; 1985; 6(4):325-30. PubMed ID: 2935744
    [Abstract] [Full Text] [Related]

  • 4. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J.
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [Abstract] [Full Text] [Related]

  • 5. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure.
    Moroni F, Lombardi G, Carlà V, Lal S, Etienne P, Nair NP.
    J Neurochem; 1986 Dec; 47(6):1667-71. PubMed ID: 2430055
    [Abstract] [Full Text] [Related]

  • 6. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type.
    Mancardi GL, Liwnicz BH, Mandybur TI.
    Acta Neuropathol; 1983 Dec; 61(1):76-80. PubMed ID: 6353837
    [Abstract] [Full Text] [Related]

  • 7. [A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].
    Nakamura N.
    Rinsho Byori; 1996 Mar; 44(3):225-30. PubMed ID: 8857164
    [Abstract] [Full Text] [Related]

  • 8. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
    Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM.
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):395-404. PubMed ID: 16008823
    [Abstract] [Full Text] [Related]

  • 9. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P, Katzman R, Terry RD.
    Nature; 1980 Nov 20; 288(5788):279-80. PubMed ID: 6107862
    [Abstract] [Full Text] [Related]

  • 10. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ, Soininen H, Riekkinen PJ.
    J Neurosci Res; 1990 Dec 20; 27(4):576-86. PubMed ID: 1981917
    [Abstract] [Full Text] [Related]

  • 11. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
    Ince P, Irving D, MacArthur F, Perry RH.
    J Neurol Sci; 1991 Dec 20; 106(2):142-52. PubMed ID: 1802962
    [Abstract] [Full Text] [Related]

  • 12. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR, Boegman RJ, Jhamandas K, Beninger RJ.
    Can J Physiol Pharmacol; 1986 Mar 20; 64(3):369-75. PubMed ID: 2939936
    [Abstract] [Full Text] [Related]

  • 13. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.
    Reinikainen KJ, Riekkinen PJ, Paljärvi L, Soininen H, Helkala EL, Jolkkonen J, Laakso M.
    Neurochem Res; 1988 Feb 20; 13(2):135-46. PubMed ID: 3362291
    [Abstract] [Full Text] [Related]

  • 14. The nucleus basalis in Huntington's disease.
    Clark AW, Parhad IM, Folstein SE, Whitehouse PJ, Hedreen JC, Price DL, Chase GA.
    Neurology; 1983 Oct 20; 33(10):1262-7. PubMed ID: 6225032
    [Abstract] [Full Text] [Related]

  • 15. [An autopsy case of senile dementia with numerous neocortical senile plaques and preserved subcortical nuclei].
    Wakabayashi K, Takahashi H, Ikuta F, Homma Y.
    Rinsho Shinkeigaku; 1989 Sep 20; 29(9):1163-7. PubMed ID: 2598544
    [Abstract] [Full Text] [Related]

  • 16. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA, Davies P.
    J Neurochem; 1982 Jun 20; 38(6):1781-4. PubMed ID: 6176686
    [Abstract] [Full Text] [Related]

  • 17. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis.
    Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B.
    Acta Neuropathol; 1987 Jun 20; 74(3):209-25. PubMed ID: 3673513
    [Abstract] [Full Text] [Related]

  • 18. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.
    Arendt T, Bigl V, Tennstedt A, Arendt A.
    Neuroscience; 1985 Jan 20; 14(1):1-14. PubMed ID: 3974875
    [Abstract] [Full Text] [Related]

  • 19. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
    Danielsson E, Eckernäs SA, Westlind-Danielsson A, Nordström O, Bartfai T, Gottfries CG, Wallin A.
    Neurobiol Aging; 1988 Jan 20; 9(2):153-62. PubMed ID: 2897639
    [Abstract] [Full Text] [Related]

  • 20. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
    Jhamandas K, Boegman RJ, Beninger RJ, Bialik M.
    Brain Res; 1990 Oct 08; 529(1-2):185-91. PubMed ID: 2149296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.